Provided by Tiger Fintech (Singapore) Pte. Ltd.

Treace Medical Concepts, Inc.

7.70
0.0000
Volume:55.18K
Turnover:422.68K
Market Cap:486.43M
PE:-9.76
High:7.78
Open:7.55
Low:7.55
Close:7.70
52wk High:10.79
52wk Low:4.54
Shares:63.17M
Float Shares:47.24M
Volume Ratio:0.44
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7886
EPS(LYR):-0.8975
ROE:-46.89%
ROA:-13.83%
PB:4.98
PE(LYR):-8.58

Loading ...

Treace Medical Concepts: Positive Q2 Earnings Call Highlights

TIPRANKS
·
Aug 13

Truist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)

TIPRANKS
·
Aug 11

Treace Medical Concepts Is Maintained at Neutral by UBS

Dow Jones
·
Aug 09

J.P. Morgan Keeps Their Hold Rating on Treace Medical Concepts (TMCI)

TIPRANKS
·
Aug 09

UBS Adjusts Treace Medical Concepts Price Target to $6.50 From $8.60, Maintains Neutral Rating

MT Newswires Live
·
Aug 08

BTIG Reaffirms Their Buy Rating on Treace Medical Concepts (TMCI)

TIPRANKS
·
Aug 08

Treace Medical Q2 revenue edges above estimates

Reuters
·
Aug 08

Treace Medical Concepts Q2 EPS $(0.28) Beats $(0.29) Estimate, Sales $47.387M Beat $47.077M Estimate

Benzinga
·
Aug 08

Treace Medical Concepts Reports Second Quarter 2025 Financial Results

GlobeNewswire
·
Aug 08

Treace Medical Concepts Inc. to Host Investor Day Highlighting New Products in New York

Reuters
·
Aug 08

Treace Medical publishes four-year interim results from ALIGN3D study

TIPRANKS
·
Aug 06

Treace Medical Concepts Announces Four-Year Results of ALIGN3D™ Study, Showcasing Positive Outcomes of Lapiplasty® Procedure for Bunion Treatment

Reuters
·
Aug 06

Treace Medical Concepts Inc. to Announce Second Quarter 2025 Financial Results

Reuters
·
Jul 25

Treace Medical Concepts Inc. Files Patent Infringement Lawsuit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology

Reuters
·
Jun 06

TMCI Lawsuit Alert! Class Action Lawsuit Against Treace Medical Concepts

TIPRANKS
·
May 23

Treace Medical Elects Directors at Annual Meeting

TIPRANKS
·
May 22

Treace Medical Concepts Inc. Concluded Annual Stockholders Meeting

Reuters
·
May 22

Medical Technology Firms Face Price Target Revisions From Morgan Stanley

MT Newswires Live
·
May 14

Morgan Stanley Cuts Price Target on Treace Medical Concepts to $8 From $10, Maintains Equalweight Rating

MT Newswires Live
·
May 13

Analysts’ Opinions Are Mixed on These Healthcare Stocks: InflaRx (IFRX), Treace Medical Concepts (TMCI) and Amarin (AMRN)

TIPRANKS
·
May 12